GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
Open Access
- 6 March 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 7 (1), srep43395
- https://doi.org/10.1038/srep43395
Abstract
GS-5734 is a monophosphate prodrug of an adenosine nucleoside analog that showed therapeutic efficacy in a non-human primate model of Ebola virus infection. It has been administered under compassionate use to two Ebola patients, both of whom survived, and is currently in Phase 2 clinical development for treatment of Ebola virus disease. Here we report the antiviral activities of GS-5734 and the parent nucleoside analog across multiple virus families, providing evidence to support new indications for this compound against human viruses of significant public health concern.Keywords
This publication has 31 references indexed in Scilit:
- Taxonomy of the order Mononegavirales: update 2016Archiv für die gesamte Virusforschung, 2016
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeysNature, 2016
- Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and ResistanceViruses, 2015
- Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent proteinVirology, 2015
- Live-Attenuated Measles Virus Vaccine Targets Dendritic Cells and Macrophages in Muscle of Nonhuman PrimatesJournal of Virology, 2015
- Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screeningAntiviral Research, 2014
- Development of a reverse genetics system to generate recombinant Marburg virus derived from a bat isolateVirology, 2013
- Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosidesBioorganic & Medicinal Chemistry Letters, 2012
- Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudineAntiviral Research, 2010
- Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screeningVirology, 2005